Intrinsic Value of S&P & Nasdaq Contact Us

Lantheus Holdings, Inc. LNTH NASDAQ

NASDAQ Global Market • Healthcare • Drug Manufacturers - Specialty & Generic • US • USD

SharesGrow Score
83/100
7/7 Pass
SharesGrow Intrinsic Value
$158.94
+92.1%
Analyst Price Target
$87.00
+5.1%

Stock Statistics — LNTH

Lantheus Holdings, Inc. (LNTH) has a market capitalization of $5.39B and trades at $82.74. The 52-week range is 47.25-108.91.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of 23.9, Earnings Per Share (EPS) of $3.46, annual revenue of $1.54B.

The stock has a beta of -0.13, operates in the Healthcare sector.

Trading Data
Current Price$82.74
52-Week Range47.25-108.91
Volume537.28K
Avg Volume (30D)946.34K
Market Cap$5.39B
Beta (1Y)-0.13
Company
IPO Date2015-06-25
Employees808
CEOMary Anne Heino
CountryUS
ExchangeNASDAQ Global Market
CurrencyUSD
ISINUS5165441032
CUSIP516544103
Income (Latest Year)
Revenue$1.54B
Gross Profit$941.95M
EBITDA$403.64M
Operating Income$310.83M
Net Income$233.56M
EPS$3.46
EPS Diluted$3.41
Shares Outstanding$67.49M
Balance Sheet (Latest Year)
Total Assets$2.23B
Current Assets$899.96M
Cash & ST Investments$359.12M
Total Liabilities$1.14B
Total Debt$738K
Net Debt$-358.38M
Total Equity$1.09B
Debt / Equity0.00
Valuation Ratios
P/E Ratio23.9
P/S Ratio3.49
P/B Ratio4.94
EV/EBITDA (approx)13.3
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message